title: Treatment of bulimia with nomifensine.
abstract: The authors treated 12 consecutive bulimic patients with nomifensine, a novel antidepressant recently approved for American use. Two patients developed fever, necessitating discontinuation of the drug. Of the other 10 patients, nine showed moderate or better improvement, with strikingly few side effects.
authors.forename: H G
authors.initials: HG
authors.lastname: Pope
authors.forename: P L
authors.initials: PL
authors.lastname: Herridge
authors.forename: J I
authors.initials: JI
authors.lastname: Hudson
authors.forename: R
authors.initials: R
authors.lastname: Fontaine
authors.forename: D
authors.initials: D
authors.lastname: Yurgelun-Todd
mesh_terms: D000328:Adult; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D009627:Nomifensine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D009627:Nomifensine